Vitamin D and Its Analog EB1089 Induce p27 Accumulation and Diminish Association of p27 with Skp2 Independent of PTEN in Pituitary Corticotroph Cells

Disruption of the gene for the cyclin dependent kinase inhibitor (CDKI) p27/kip1 results in pituitary corticotroph hyperplasia while diminished expression of this protein has been described in aggressive human pituitary tumors. We have previously shown that 1,25‐vitamin D3 (VD) hypophosphorylates p27 and interferes with the degradation of this CDKI in thyroid carcinoma cells. In this study we investigated whether VD/EB1089 can induce p27 accumulation and cause growth arrest of pituitary corticotroph cells. VD and EB1089 exhibited a significant reduction in AtT20 corticotroph but not PRL235 Iactotroph cell growth. These changes were accompanied by selective accumulation of p27 in AtT20 but not in PRL235 cells. As p27 levels are highly dependent on protein degradation, we examined the effect of VD/EB1089 on p27 association with factors that target this CDKI to the proteasome. VD/EB1089 significantly restricted the association of p27 with Skp2 as well as with cyclin dependent kinase 2 (CDK2). As the tumor suppressor and phosphatase PTEN has been implicated in p27 regulation, we tested whether the effects of VD/EB1089 on p27 accumulation in corticotrophs could be mediated through this pathway. VD/EB1089 did not appreciably alter PTEN expression. Moreover, transfection of PTEN did not influence the effect of VD on p27 accumulation in corticotrophs. We conclude that VD/EB1089 can selectively arrest pituitary corticotroph growth and induce p27 accumulation. This effect is mediated at least partially through diminished p27 association with Skp2 and with CDK2. In contrast to other cell systems, PTEN does not participate in the regulation of corticotroph p27 and is not involved in mediating the effect of VD on p27 in these cells. Our findings highlight p27 and VD analogs as targets for manipulation and drug development respectively in the treatment of inoperable corticotroph adenomas.

[1]  武藤 章弘.  1,25-dihydroxyvitamin D3 induces differentiation of a retinoic acid-resistant acute promyelocytic leukemia cell line (UF-1) associated with expression of p21WAF1/CIP1 and p27KIP1 , 2003 .

[2]  Wei Liu,et al.  Vitamin D arrests thyroid carcinoma cell growth and induces p27 dephosphorylation and accumulation through PTEN/akt-dependent and -independent pathways. , 2002, The American journal of pathology.

[3]  I. Sunada,et al.  Immunohistochemical Analyses of Cell Cycle-related Proteins, Apoptosis, and Proliferation in Pituitary Adenomas , 2001, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[4]  R. Mamillapalli,et al.  PTEN regulates the ubiquitin-dependent degradation of the CDK inhibitor p27KIP1 through the ubiquitin E3 ligase SCFSKP2 , 2001, Current Biology.

[5]  M. Korbonits,et al.  Cyclin D and cyclin E expression in normal and adenomatous pituitary. , 2000, European journal of endocrinology.

[6]  G. Viglietto,et al.  PTEN expression is reduced in a subset of sporadic thyroid carcinomas: evidence that PTEN-growth suppressing activity in thyroid cancer cells is mediated by p27kip1 , 2000, Oncogene.

[7]  R. Bouillon,et al.  Two novel 14-Epi-analogues of 1,25-dihydroxyvitamin D3 inhibit the growth of human breast cancer cells in vitro and in vivo. , 2000, Cancer research.

[8]  J. Yeh,et al.  Differential nuclear and cytoplasmic expression of PTEN in normal thyroid tissue, and benign and malignant epithelial thyroid tumors. , 2000, The American journal of pathology.

[9]  I. Weinstein,et al.  Multiple functions of p27Kip1 and its alterations in tumor cells: a review , 2000, Journal of cellular physiology.

[10]  T. Sakai,et al.  Sp1 and NF-Y Synergistically Mediate the Effect of Vitamin D3 in the p27Kip1 Gene Promoter That Lacks Vitamin D Response Elements* , 1999, The Journal of Biological Chemistry.

[11]  M. Korbonits,et al.  Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors. , 1999, The Journal of clinical endocrinology and metabolism.

[12]  P. Hershberger,et al.  1,25-Dihydroxycholecalciferol (1,25-D3) inhibits the growth of squamous cell carcinoma and down-modulates p21(Waf1/Cip1) in vitro and in vivo. , 1999, Cancer research.

[13]  R. Boland,et al.  Rapid actions of calcitriol and its side chain analogues CB1093 and GS1500 on intracellular calcium levels in skeletal muscle cells: a comparative study , 1999, British journal of pharmacology.

[14]  H. Koeffler,et al.  1,25-Dihydroxyvitamin D3 induces differentiation of a retinoic acid-resistant acute promyelocytic leukemia cell line (UF-1) associated with expression of p21(WAF1/CIP1) and p27(KIP1). , 1999, Blood.

[15]  D. Lüdecke,et al.  Reduced expression levels of the cell-cycle inhibitor p27Kip1 in human pituitary adenomas. , 1999, European journal of endocrinology.

[16]  C. Cordon-Cardo,et al.  Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[17]  A. Koff,et al.  Cell-Free Degradation of p27kip1, a G1 Cyclin-Dependent Kinase Inhibitor, Is Dependent on CDK2 Activity and the Proteasome , 1999, Molecular and Cellular Biology.

[18]  J. Jen,et al.  Somatic mutations of the PTEN tumor suppressor gene in sporadic follicular thyroid tumors , 1998, Genes, chromosomes & cancer.

[19]  T. Mak,et al.  High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice , 1998, Current Biology.

[20]  P. Mäenpää,et al.  Inhibition of proliferation and induction of differentiation of osteoblastic cells by a novel 1,25‐dihydroxyvitamin D3 analog with an extensively modified side chain (CB1093) , 1998, Journal of cellular biochemistry.

[21]  W. Hong,et al.  Alterations of PTEN/MMAC1, a candidate tumor suppressor gene, and its homologue, PTH2, in small cell lung cancer cell lines , 1998, Oncogene.

[22]  R. Aguiar,et al.  Mutation and expression analysis of the p27/kip1 gene in corticotrophin-secreting tumours , 1998, Oncogene.

[23]  G. Mills,et al.  MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines. , 1997, Cancer research.

[24]  G. Sledge,et al.  Effects of vitamin D3 on proliferation of cancer cells in vitro. , 1997, Cancer letters.

[25]  C. Larsson,et al.  Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors. , 1997, Cancer research.

[26]  M. Brattain,et al.  Modulation of cell cycle control by vitamin D3 and its analogue, EB1089, in human breast cancer cells , 1997, Oncogene.

[27]  L. Jin,et al.  Aberrant p27kip1 expression in endocrine and other tumors. , 1997, The American journal of pathology.

[28]  R. Perez-Fernandez,et al.  Vitamin D receptor gene expression in human pituitary gland. , 1996, Life sciences.

[29]  T. Nikaido,et al.  Vitamin D analogues up-regulate p21 and p27 during growth inhibition of pancreatic cancer cell lines. , 1997, British Journal of Cancer.

[30]  Nobuyuki Shishido,et al.  Mice Lacking p27 Kip1 Display Increased Body Size, Multiple Organ Hyperplasia, Retinal Dysplasia, and Pituitary Tumors , 1996, Cell.

[31]  James M. Roberts,et al.  A Syndrome of Multiorgan Hyperplasia with Features of Gigantism, Tumorigenesis, and Female Sterility in p27 Kip1 -Deficient Mice , 1996, Cell.

[32]  K. Manova-Todorova,et al.  Enhanced Growth of Mice Lacking the Cyclin-Dependent Kinase Inhibitor Function of p27 Kip1 , 1996, Cell.

[33]  A. Aranda,et al.  Vitamin D interferes with transactivation of the growth hormone gene by thyroid hormone and retinoic acid , 1996, Molecular and cellular biology.

[34]  J. Wark,et al.  1,25-Dihydroxyvitamin D3-induced upregulation of the thyrotropin-releasing hormone receptor in clonal rat pituitary GH3 cells. , 1995, The Journal of endocrinology.

[35]  P. Beer-Romero,et al.  Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. , 1995, Science.

[36]  C. Bartram,et al.  Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies. , 1995, Cancer research.

[37]  P. Torjesen,et al.  Calcitriol attenuates the thyrotropin-releasing hormone-stimulated inositol phosphate production in clonal rat pituitary (GH4C1 ) cells , 1993, Molecular and Cellular Endocrinology.

[38]  J. Rehfeld,et al.  Gastrin in pituitary tumours. , 1987, Acta endocrinologica.